切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Protease-Activated Receptors - M2 Receptors - Insulin and Insulin-like Receptors - eIF4F

10 件产品

每页
清除全部
  1. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: eIF4E:eIF4G与eIF4E:4E-BP1相互作用的双重抑制剂
      ≥23.85 mg/mL
      insoluble in H2O
  2. Gallamine Triethiodide
    B1610 Gallamine Triethiodide
    中文名: 加拉碘铵,弛肌碘,戈拉碘铵
    Target: M2 Receptors
    Summary: 胆碱能受体阻断剂
      ≥44.58 mg/mL
      ≥54.6 mg/mL
  3. Vorapaxar
    A8809 Vorapaxar
    中文名: 沃拉帕沙
    Target: Protease-Activated Receptors
    Summary: PAR-1拮抗剂
      ≥24.65 mg/mL
      insoluble in H2O
  4. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  5. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL
  6. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  7. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  8. ML161
    A8229 ML161
    Target: Protease-Activated Receptors
    Summary: PAR1抑制剂
      ≥16.4 mg/mL
      insoluble in H2O
  9. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  10. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O

10 件产品

每页